Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11069
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHuynh, Nhien
dc.contributor.authorLiu, Kevin Hen
dc.contributor.authorBaldwin, Graham Sen
dc.contributor.authorHe, Hongen
dc.date.accessioned2015-05-16T00:38:53Z
dc.date.available2015-05-16T00:38:53Z
dc.date.issued2010-06-01en
dc.identifier.citationBiochimica Et Biophysica Acta 2010; 1803(9): 1106-13en
dc.identifier.govdoc20595063en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11069en
dc.description.abstractThe p21-activated kinase (PAK) family of serine/threonine kinases plays an important role in cell proliferation, survival and motility, as well as in cell transformation and tumor progression. PAK1 promotes transformation through facilitating the ERK/MAPK pathway and enhances cell migration and survival by stimulating AKT. PAK1 expression increases with the progression of colorectal cancer (CRC). In this study, we have investigated the importance of PAK1 in the biology of colon cancer cells. Reduction of PAK1 expression decreased the activities of ERK and AKT leading to decreased cell proliferation, migration/invasion, and survival. Dual inhibition of ERK and AKT suppressed these cellular processes to levels comparable to those achieved by reduction of PAK1 expression, whereas inactivation of either the ERK or AKT pathway alone partially inhibited cell migration/invasion and survival and had no effect on proliferation. We conclude that PAK1 stimulates colon cancer cell proliferation, migration/invasion, and survival via ERK- and AKT-dependent pathways. These findings establish the central importance of PAK1 in CRC signal transduction and clarify the mechanism by which PAK1 regulates CRC growth and migration. Instead of simultaneously inhibiting both ERK and AKT, the PAK1 convergence point could be an alternative target for CRC therapy.en
dc.language.isoenen
dc.subject.otherCarcinoma.genetics.metabolism.pathologyen
dc.subject.otherCell Movement.drug effects.genetics.physiologyen
dc.subject.otherCell Proliferation.drug effectsen
dc.subject.otherCell Survival.drug effects.geneticsen
dc.subject.otherColonic Neoplasms.genetics.metabolism.pathologyen
dc.subject.otherExtracellular Signal-Regulated MAP Kinases.metabolism.physiologyen
dc.subject.otherHCT116 Cellsen
dc.subject.otherHumansen
dc.subject.otherMAP Kinase Signaling System.drug effects.physiologyen
dc.subject.otherModels, Biologicalen
dc.subject.otherNeoplasm Invasivenessen
dc.subject.otherOncogene Protein v-akt.metabolism.physiologyen
dc.subject.otherRNA, Small Interfering.pharmacologyen
dc.subject.otherSignal Transduction.drug effects.genetics.physiologyen
dc.subject.otherTumor Cells, Cultureden
dc.subject.otherp21-Activated Kinases.antagonists & inhibitors.genetics.physiologyen
dc.titleP21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways.en
dc.typeJournal Articleen
dc.identifier.journaltitleBiochimica et biophysica actaen
dc.identifier.affiliationDepartment of Surgery, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia 3084, Australiaen
dc.identifier.doi10.1016/j.bbamcr.2010.05.007en
dc.description.pages1106-13en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/20595063en
dc.type.austinJournal Articleen
local.name.researcherHe, Hong
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptSurgery (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Oct 3, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.